Placental isoferritin associated p43 antigen correlates with features of high differentiation in breast cancer

[1]  Michael Stierer,et al.  Nuclear pleomorphism, a strong prognostic factor in axillary node-negative small invasive breast cancer , 1991, Breast Cancer Research and Treatment.

[2]  M. Stierer,et al.  Nuclear polymorphism — a prognostic parameter to evaluate local recurrence of female breast cancer , 1990, Breast Cancer Research and Treatment.

[3]  D. Pieper,et al.  Tissue ferritin concentration and prognosis in carcinoma of the breast , 1989, Breast Cancer Research and Treatment.

[4]  B. Hazaz,et al.  Characterization of T-lymphocyte subpopulations infiltrating primary breast cancer , 2004, Cancer Immunology, Immunotherapy.

[5]  M. Eibl,et al.  Determination of placental ferritin-positive peripheral lymphocytes in early stages of breast cancer. , 1993, American journal of surgery.

[6]  M. Toi,et al.  Inhibition of colon and breast carcinoma cell growth by interleukin-4. , 1992, Cancer research.

[7]  D. Flex,et al.  Monoclonal antibody CM-H-9 detects circulating placental isoferritin in the serum of patients with visceral metastases of breast cancer. , 1991, Cancer letters.

[8]  E. Mallon,et al.  Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer. , 1990, British Journal of Cancer.

[9]  R. Maymon,et al.  Placental Isoferritin Measured by a Specific Monoclonal Antibody as a Predictive Marker for Preterm Contraction Outcome , 1989, Obstetrics and gynecology.

[10]  Elaine Ron,et al.  The use of oncofetal ferritin‐bearing lymphocytes as a marker for the screening, diagnosis, and follow‐up of patients with early breast malignancy screening of 3400 women , 1989, Cancer.

[11]  R. Walker,et al.  Immunohistochemical analysis of HLA antigens and mononuclear infiltrates of benign and malignant breast , 1987, The Journal of pathology.

[12]  Y. Lurie,et al.  New monoclonal antibody enzymoassay for the specific measurement of placental ferritin isotype in hematologic malignancies. , 1987, Experimental hematology.

[13]  R C Coombes,et al.  Immunocytochemical assay for estrogen receptor in patients with breast cancer: relationship to a biochemical assay and to outcome of therapy. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  B. Parhami-Seren,et al.  Preparation and characterization of monoclonal antibodies specific to placenta ferritin. , 1985, Clinica chimica acta; international journal of clinical chemistry.

[15]  H Wiebelt,et al.  CRITLEVEL: An Exploratory Procedure for the Evaluation of Quantitative Prognostic Factors , 1984, Methods of Information in Medicine.

[16]  B. Silberberg,et al.  Tissue ferritin concentration in carcinoma of the breast , 1982, Cancer.

[17]  M. Worwood,et al.  Serum ferritin in patients with cancer: determination with antibodies to HeLa cell and spleen ferritin. , 1980, Clinica chimica acta; international journal of clinical chemistry.

[18]  D. J. Lavoie,et al.  Characterization of ferritin from human placenta. Implications for analysis of tissue specificity and microheterogeneity of ferritins. , 1979, Biochimica et biophysica acta.

[19]  M. Radu,et al.  Establishment and characterization of a cell line of human breast carcinoma origin. , 1979, European journal of cancer.

[20]  P. Fraker,et al.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. , 1978, Biochemical and biophysical research communications.

[21]  L. Moroz Increased blood fibrinolytic activity after aspirin ingestion. , 1977, The New England journal of medicine.

[22]  P. Arosio,et al.  Immunologic differences in human isoferritins: implications for immunologic quantitation of serum ferritin. , 1977, Blood.

[23]  E. Alpert,et al.  CARCINOFETAL HUMAN ISOFERRITINS * , 1975, Annals of the New York Academy of Sciences.

[24]  N. Zinberg,et al.  Isolation of ferritin from human mammary and pancreatic carcinomas by means of antibody immunoadsorbents. , 1974, Archives of biochemistry and biophysics.

[25]  A. Long,et al.  A human cell line from a pleural effusion derived from a breast carcinoma. , 1973, Journal of the National Cancer Institute.

[26]  David R. Cox,et al.  Regression models and life tables (with discussion , 1972 .

[27]  N. Mantel Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.

[28]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .